Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Sales by segment of business
Sales to customers	$ 20,348	$ 19,650	$ 61,187	$ 56,255
Percent Change (as a percent)	3.60%		8.80%
U.S.
Sales by segment of business
Sales to customers	$ 10,664	10,290	$ 31,255	29,394
Percent Change (as a percent)	3.60%		6.30%
International
Sales by segment of business
Sales to customers	$ 9,684	9,360	$ 29,932	26,861
Percent Change (as a percent)	3.50%		11.40%
CONSUMER
Sales by segment of business
Sales to customers	$ 3,415	3,356	$ 10,317	10,062
Percent Change (as a percent)	1.80%		2.50%
CONSUMER | U.S.
Sales by segment of business
Sales to customers	$ 1,370	1,285	$ 4,282	4,186
Percent Change (as a percent)	6.60%		2.30%
CONSUMER | International
Sales by segment of business
Sales to customers	$ 2,045	2,071	$ 6,035	5,876
Percent Change (as a percent)	(1.30%)		2.70%
CONSUMER | Baby Care
Sales by segment of business
Sales to customers	$ 472	477	$ 1,385	1,426
Percent Change (as a percent)	(1.00%)		(2.90%)
CONSUMER | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 120	100	$ 306	326
Percent Change (as a percent)	20.00%		(6.10%)
CONSUMER | Baby Care | International
Sales by segment of business
Sales to customers	$ 352	377	$ 1,079	1,100
Percent Change (as a percent)	(6.60%)		(1.90%)
CONSUMER | Beauty
Sales by segment of business
Sales to customers	$ 1,078	1,033	$ 3,271	3,090
Percent Change (as a percent)	4.40%		5.90%
CONSUMER | Beauty | U.S.
Sales by segment of business
Sales to customers	$ 543	523	$ 1,791	1,739
Percent Change (as a percent)	3.80%		3.00%
CONSUMER | Beauty | International
Sales by segment of business
Sales to customers	$ 535	510	$ 1,480	1,351
Percent Change (as a percent)	4.90%		9.50%
CONSUMER | Oral Care
Sales by segment of business
Sales to customers	$ 384	382	$ 1,156	1,138
Percent Change (as a percent)	0.50%		1.60%
CONSUMER | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 158	154	$ 472	460
Percent Change (as a percent)	2.60%		2.60%
CONSUMER | Oral Care | International
Sales by segment of business
Sales to customers	$ 226	228	$ 684	678
Percent Change (as a percent)	(0.90%)		0.90%
CONSUMER | OTC
Sales by segment of business
Sales to customers	$ 1,048	1,002	$ 3,186	3,021
Percent Change (as a percent)	4.60%		5.50%
CONSUMER | OTC | U.S.
Sales by segment of business
Sales to customers	$ 440	401	$ 1,359	1,310
Percent Change (as a percent)	9.70%		3.70%
CONSUMER | OTC | International
Sales by segment of business
Sales to customers	$ 608	601	$ 1,827	1,711
Percent Change (as a percent)	1.20%		6.80%
CONSUMER | Women's Health
Sales by segment of business
Sales to customers	$ 269	270	$ 792	788
Percent Change (as a percent)	(0.40%)		0.50%
CONSUMER | Women's Health | U.S.
Sales by segment of business
Sales to customers	$ 3	3	$ 10	9
Percent Change (as a percent)	0.00%		11.10%
CONSUMER | Women's Health | International
Sales by segment of business
Sales to customers	$ 266	267	$ 782	779
Percent Change (as a percent)	(0.40%)		0.40%
CONSUMER | Wound Care/Other
Sales by segment of business
Sales to customers	$ 164	192	$ 527	599
Percent Change (as a percent)	(14.60%)		(12.00%)
CONSUMER | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 106	104	$ 344	342
Percent Change (as a percent)	1.90%		0.60%
CONSUMER | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 58	88	$ 183	257
Percent Change (as a percent)	(34.10%)		(28.80%)
PHARMACEUTICAL
Sales by segment of business
Sales to customers	$ 10,346	9,695	$ 30,544	26,575
Percent Change (as a percent)	6.70%		14.90%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales to customers	$ 6,097	5,816	$ 17,350	15,698
Percent Change (as a percent)	4.80%		10.50%
PHARMACEUTICAL | International
Sales by segment of business
Sales to customers	$ 4,249	3,879	$ 13,194	10,877
Percent Change (as a percent)	9.50%		21.30%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales to customers	$ 3,398	3,269	$ 9,778	9,158
Percent Change (as a percent)	3.90%		6.80%
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,400	2,420	$ 6,717	6,644
Percent Change (as a percent)	(0.80%)		1.10%
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales to customers	$ 998	849	$ 3,061	2,514
Percent Change (as a percent)	17.60%		21.80%
PHARMACEUTICAL | Immunology | REMICADE®
Sales by segment of business
Sales to customers	$ 1,379	1,647	$ 4,088	4,849
Percent Change (as a percent)	(16.30%)		(15.70%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S.
Sales by segment of business
Sales to customers	$ 987	1,206	$ 2,821	3,452
Percent Change (as a percent)	(18.20%)		(18.30%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports
Sales by segment of business
Sales to customers	$ 100	156	$ 346	448
Percent Change (as a percent)	(35.90%)		(22.80%)
PHARMACEUTICAL | Immunology | REMICADE® | International
Sales by segment of business
Sales to customers	$ 292	285	$ 921	949
Percent Change (as a percent)	2.50%		(3.00%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®
Sales by segment of business
Sales to customers	$ 536	476	$ 1,602	1,343
Percent Change (as a percent)	12.60%		19.30%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.
Sales by segment of business
Sales to customers	$ 281	242	$ 779	701
Percent Change (as a percent)	16.10%		11.10%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International
Sales by segment of business
Sales to customers	$ 255	234	$ 823	642
Percent Change (as a percent)	9.00%		28.20%
PHARMACEUTICAL | Immunology | STELARA®
Sales by segment of business
Sales to customers	$ 1,310	1,124	$ 3,712	2,930
Percent Change (as a percent)	16.50%		26.70%
PHARMACEUTICAL | Immunology | STELARA® | U.S.
Sales by segment of business
Sales to customers	$ 889	800	$ 2,460	2,027
Percent Change (as a percent)	11.10%		21.40%
PHARMACEUTICAL | Immunology | STELARA® | International
Sales by segment of business
Sales to customers	$ 421	324	$ 1,252	903
Percent Change (as a percent)	29.90%		38.60%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 173	22	$ 376	36
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	143	16	311	16
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	30	6	65	20
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales to customers	$ 823	813	$ 2,502	2,354
Percent Change (as a percent)	1.20%		6.30%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 345	353	$ 1,006	1,020
Percent Change (as a percent)	(2.30%)		(1.40%)
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 478	460	$ 1,496	1,334
Percent Change (as a percent)	3.90%		12.10%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine
Sales by segment of business
Sales to customers	$ 202	194	$ 623	522
Percent Change (as a percent)	4.10%		19.30%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 13	15	$ 42	44
Percent Change (as a percent)	(13.30%)		(4.50%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International
Sales by segment of business
Sales to customers	$ 189	179	$ 581	478
Percent Change (as a percent)	5.60%		21.50%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
Sales by segment of business
Sales to customers	$ 490	467	$ 1,460	1,351
Percent Change (as a percent)	4.90%		8.10%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.
Sales by segment of business
Sales to customers	$ 297	287	$ 847	824
Percent Change (as a percent)	3.50%		2.80%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International
Sales by segment of business
Sales to customers	$ 193	180	$ 613	527
Percent Change (as a percent)	7.20%		16.30%
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales to customers	$ 131	152	$ 419	481
Percent Change (as a percent)	(13.80%)		(12.90%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales to customers	$ 35	51	$ 117	152
Percent Change (as a percent)	(31.40%)		(23.00%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales to customers	$ 96	101	$ 302	329
Percent Change (as a percent)	(5.00%)		(8.20%)
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales to customers	$ 1,490	1,498	$ 4,577	4,462
Percent Change (as a percent)	(0.50%)		2.60%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 651	647	$ 1,914	1,931
Percent Change (as a percent)	0.60%		(0.90%)
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales to customers	$ 839	851	$ 2,663	2,531
Percent Change (as a percent)	(1.40%)		5.20%
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate
Sales by segment of business
Sales to customers	$ 157	198	$ 513	588
Percent Change (as a percent)	(20.70%)		(12.80%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 57	100	$ 191	284
Percent Change (as a percent)	(43.00%)		(32.70%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | International
Sales by segment of business
Sales to customers	$ 100	98	$ 322	304
Percent Change (as a percent)	2.00%		5.90%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA®
Sales by segment of business
Sales to customers	$ 749	643	$ 2,165	1,876
Percent Change (as a percent)	16.50%		15.40%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA® | U.S.
Sales by segment of business
Sales to customers	$ 468	395	$ 1,306	1,154
Percent Change (as a percent)	18.50%		13.20%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA® | International
Sales by segment of business
Sales to customers	$ 281	248	$ 859	722
Percent Change (as a percent)	13.30%		19.00%
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®
Sales by segment of business
Sales to customers	$ 175	194	$ 559	608
Percent Change (as a percent)	(9.80%)		(8.10%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.
Sales by segment of business
Sales to customers	$ 76	87	$ 238	273
Percent Change (as a percent)	(12.60%)		(12.80%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International
Sales by segment of business
Sales to customers	$ 99	107	$ 321	335
Percent Change (as a percent)	(7.50%)		(4.20%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 409	463	$ 1,340	1,390
Percent Change (as a percent)	(11.70%)		(3.60%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 50	65	$ 179	220
Percent Change (as a percent)	(23.10%)		(18.60%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 359	398	$ 1,161	1,170
Percent Change (as a percent)	(9.80%)		(0.80%)
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales to customers	$ 2,588	1,898	$ 7,355	5,219
Percent Change (as a percent)	36.40%		40.90%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,250	846	$ 3,268	2,207
Percent Change (as a percent)	47.80%		48.10%
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales to customers	$ 1,338	1,052	$ 4,087	3,012
Percent Change (as a percent)	27.20%		35.70%
PHARMACEUTICAL | Oncology | DARZALEX®
Sales by segment of business
Sales to customers	$ 498	317	$ 1,441	871
Percent Change (as a percent)	57.10%		65.40%
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.
Sales by segment of business
Sales to customers	$ 318	230	$ 880	643
Percent Change (as a percent)	38.30%		36.90%
PHARMACEUTICAL | Oncology | DARZALEX® | International
Sales by segment of business
Sales to customers	$ 180	87	$ 561	228
PHARMACEUTICAL | Oncology | IMBRUVICA®
Sales by segment of business
Sales to customers	$ 705	512	$ 1,912	1,371
Percent Change (as a percent)	37.70%		39.50%
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.
Sales by segment of business
Sales to customers	$ 334	230	$ 811	622
Percent Change (as a percent)	45.20%		30.40%
PHARMACEUTICAL | Oncology | IMBRUVICA® | International
Sales by segment of business
Sales to customers	$ 371	282	$ 1,101	749
Percent Change (as a percent)	31.60%		47.00%
PHARMACEUTICAL | Oncology | VELCADE®
Sales by segment of business
Sales to customers	$ 271	273	$ 864	843
Percent Change (as a percent)	(0.70%)		2.50%
PHARMACEUTICAL | Oncology | VELCADE® | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Oncology | VELCADE® | International
Sales by segment of business
Sales to customers	$ 271	273	$ 864	843
Percent Change (as a percent)	(0.70%)		2.50%
PHARMACEUTICAL | Oncology | ZYTIGA®
Sales by segment of business
Sales to customers	$ 958	669	$ 2,712	1,750
Percent Change (as a percent)	43.20%		55.00%
PHARMACEUTICAL | Oncology | ZYTIGA® | U.S.
Sales by segment of business
Sales to customers	$ 527	352	$ 1,420	826
Percent Change (as a percent)	49.70%		71.90%
PHARMACEUTICAL | Oncology | ZYTIGA® | International
Sales by segment of business
Sales to customers	$ 431	317	$ 1,292	924
Percent Change (as a percent)	36.00%		39.80%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 156	127	$ 426	384
Percent Change (as a percent)	22.80%		10.90%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 71	34	$ 157	116
Percent Change (as a percent)			35.30%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 85	93	$ 269	268
Percent Change (as a percent)	(8.60%)		0.40%
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 656	632	$ 1,906	717
Percent Change (as a percent)	3.80%
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 425	371	1,215	408
Percent Change (as a percent)	14.60%
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 231	261	691	309
Percent Change (as a percent)	(11.50%)
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®
Sales by segment of business
Sales to customers	$ 310	259	892	304
Percent Change (as a percent)	19.70%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.
Sales by segment of business
Sales to customers	$ 182	150	511	174
Percent Change (as a percent)	21.30%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International
Sales by segment of business
Sales to customers	$ 128	109	381	130
Percent Change (as a percent)	17.40%
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER®
Sales by segment of business
Sales to customers	$ 139	210	422	236
Percent Change (as a percent)	(33.80%)
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | U.S.
Sales by segment of business
Sales to customers	$ 69	83	208	85
Percent Change (as a percent)	(16.90%)
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | International
Sales by segment of business
Sales to customers	$ 70	127	214	151
Percent Change (as a percent)	(44.90%)
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®
Sales by segment of business
Sales to customers	$ 171	124	482	133
Percent Change (as a percent)	37.90%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.
Sales by segment of business
Sales to customers	$ 154	113	433	121
Percent Change (as a percent)	36.30%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International
Sales by segment of business
Sales to customers	$ 17	11	49	12
Percent Change (as a percent)	54.50%
PHARMACEUTICAL | Pulmonary Hypertension | OTHER
Sales by segment of business
Sales to customers	$ 36	39	110	44
Percent Change (as a percent)	(7.70%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | U.S.
Sales by segment of business
Sales to customers	$ 20	25	63	28
Percent Change (as a percent)	(20.00%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | International
Sales by segment of business
Sales to customers	$ 16	14	47	16
Percent Change (as a percent)	14.30%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 1,391	1,585	$ 4,426	4,665
Percent Change (as a percent)	(12.20%)		(5.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 1,026	1,179	$ 3,230	3,488
Percent Change (as a percent)	(13.00%)		(7.40%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 365	406	$ 1,196	1,177
Percent Change (as a percent)	(10.10%)		1.60%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER
Sales by segment of business
Sales to customers	$ 334	447	$ 1,137	1,291
Percent Change (as a percent)	(25.30%)		(11.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | U.S.
Sales by segment of business
Sales to customers	$ 86	156	$ 315	464
Percent Change (as a percent)	(44.90%)		(32.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | International
Sales by segment of business
Sales to customers	$ 248	291	$ 822	827
Percent Change (as a percent)	(14.80%)		(0.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®
Sales by segment of business
Sales to customers	$ 612	635	$ 1,869	1,790
Percent Change (as a percent)	(3.60%)		4.40%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.
Sales by segment of business
Sales to customers	$ 612	635	$ 1,869	1,790
Percent Change (as a percent)	(3.60%)		4.40%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®
Sales by segment of business
Sales to customers	$ 190	265	$ 653	844
Percent Change (as a percent)	(28.30%)		(22.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.
Sales by segment of business
Sales to customers	$ 150	220	$ 523	723
Percent Change (as a percent)	(31.80%)		(27.70%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International
Sales by segment of business
Sales to customers	$ 40	45	$ 130	121
Percent Change (as a percent)	(11.10%)		7.40%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®
Sales by segment of business
Sales to customers	$ 255	238	$ 767	740
Percent Change (as a percent)	7.10%		3.60%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.
Sales by segment of business
Sales to customers	$ 178	168	$ 523	511
Percent Change (as a percent)	6.00%		2.30%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International
Sales by segment of business
Sales to customers	$ 77	70	$ 244	229
Percent Change (as a percent)	10.00%		6.60%
MEDICAL DEVICES
Sales by segment of business
Sales to customers	$ 6,587	6,599	$ 20,326	19,618
Percent Change (as a percent)	(0.20%)		3.60%
MEDICAL DEVICES | U.S.
Sales by segment of business
Sales to customers	$ 3,197	3,189	$ 9,623	9,510
Percent Change (as a percent)	0.30%		1.20%
MEDICAL DEVICES | International
Sales by segment of business
Sales to customers	$ 3,390	3,410	$ 10,703	10,108
Percent Change (as a percent)	(0.60%)		5.90%
MEDICAL DEVICES | Diabetes Care
Sales by segment of business
Sales to customers	$ 315	405	$ 1,009	1,225
Percent Change (as a percent)	(22.20%)		(17.60%)
MEDICAL DEVICES | Diabetes Care | U.S.
Sales by segment of business
Sales to customers	$ 125	168	$ 371	482
Percent Change (as a percent)	(25.60%)		(23.00%)
MEDICAL DEVICES | Diabetes Care | International
Sales by segment of business
Sales to customers	$ 190	237	$ 638	743
Percent Change (as a percent)	(19.80%)		(14.10%)
MEDICAL DEVICES | Diagnostics
Sales by segment of business
Sales to customers	$ 0	0	$ 0	1
MEDICAL DEVICES | Diagnostics | U.S.
Sales by segment of business
Sales to customers	0	0	0	0
MEDICAL DEVICES | Diagnostics | International
Sales by segment of business
Sales to customers	0	0	0	1
MEDICAL DEVICES | Interventional Solutions
Sales by segment of business
Sales to customers	$ 653	553	$ 1,960	1,675
Percent Change (as a percent)	18.10%		17.00%
MEDICAL DEVICES | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 320	279	$ 947	843
Percent Change (as a percent)	14.70%		12.30%
MEDICAL DEVICES | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 333	274	$ 1,013	832
Percent Change (as a percent)	21.50%		21.80%
MEDICAL DEVICES | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,111	2,204	$ 6,623	6,772
Percent Change (as a percent)	(4.20%)		(2.20%)
MEDICAL DEVICES | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,284	1,308	$ 3,923	4,034
Percent Change (as a percent)	(1.80%)		(2.80%)
MEDICAL DEVICES | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 827	896	$ 2,700	2,738
Percent Change (as a percent)	(7.70%)		(1.40%)
MEDICAL DEVICES | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 330	328	$ 1,053	1,030
Percent Change (as a percent)	0.60%		2.20%
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 201	195	$ 621	612
Percent Change (as a percent)	3.10%		1.50%
MEDICAL DEVICES | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 129	133	$ 432	418
Percent Change (as a percent)	(3.00%)		3.30%
MEDICAL DEVICES | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 341	343	$ 1,110	1,126
Percent Change (as a percent)	(0.60%)		(1.40%)
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 215	220	$ 672	702
Percent Change (as a percent)	(2.30%)		(4.30%)
MEDICAL DEVICES | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 126	123	$ 438	424
Percent Change (as a percent)	2.40%		3.30%
MEDICAL DEVICES | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 654	662	$ 2,025	1,947
Percent Change (as a percent)	(1.20%)		4.00%
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 395	398	$ 1,196	1,179
Percent Change (as a percent)	(0.80%)		1.40%
MEDICAL DEVICES | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 259	264	$ 829	768
Percent Change (as a percent)	(1.90%)		7.90%
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER
Sales by segment of business
Sales to customers	$ 786	871	$ 2,435	2,669
Percent Change (as a percent)	(9.80%)		(8.80%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 473	495	$ 1,434	1,541
Percent Change (as a percent)	(4.40%)		(6.90%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | International
Sales by segment of business
Sales to customers	$ 313	376	$ 1,001	1,128
Percent Change (as a percent)	(16.80%)		(11.30%)
MEDICAL DEVICES | Surgery
Sales by segment of business
Sales to customers	$ 2,376	2,346	$ 7,314	7,001
Percent Change (as a percent)	1.30%		4.50%
MEDICAL DEVICES | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 1,016	1,002	$ 3,031	3,009
Percent Change (as a percent)	1.40%		0.70%
MEDICAL DEVICES | Surgery | International
Sales by segment of business
Sales to customers	$ 1,360	1,344	$ 4,283	3,992
Percent Change (as a percent)	1.20%		7.30%
MEDICAL DEVICES | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 976	923	$ 2,947	2,733
Percent Change (as a percent)	5.70%		7.80%
MEDICAL DEVICES | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 421	398	$ 1,216	1,190
Percent Change (as a percent)	5.80%		2.20%
MEDICAL DEVICES | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 555	525	$ 1,731	1,543
Percent Change (as a percent)	5.70%		12.20%
MEDICAL DEVICES | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,080	1,105	$ 3,376	3,293
Percent Change (as a percent)	(2.30%)		2.50%
MEDICAL DEVICES | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 423	430	$ 1,282	1,276
Percent Change (as a percent)	(1.60%)		0.50%
MEDICAL DEVICES | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 657	675	$ 2,094	2,017
Percent Change (as a percent)	(2.70%)		3.80%
MEDICAL DEVICES | Surgery | SPECIALTY
Sales by segment of business
Sales to customers	$ 320	318	$ 991	975
Percent Change (as a percent)	0.60%		1.60%
MEDICAL DEVICES | Surgery | SPECIALTY | U.S.
Sales by segment of business
Sales to customers	$ 172	174	$ 533	543
Percent Change (as a percent)	(1.10%)		(1.80%)
MEDICAL DEVICES | Surgery | SPECIALTY | International
Sales by segment of business
Sales to customers	$ 148	144	$ 458	432
Percent Change (as a percent)	2.80%		6.00%
MEDICAL DEVICES | Vision
Sales by segment of business
Sales to customers	$ 1,132	1,091	$ 3,420	2,944
Percent Change (as a percent)	3.80%		16.20%
MEDICAL DEVICES | Vision | U.S.
Sales by segment of business
Sales to customers	$ 452	432	$ 1,351	1,142
Percent Change (as a percent)	4.60%		18.30%
MEDICAL DEVICES | Vision | International
Sales by segment of business
Sales to customers	$ 680	659	$ 2,069	1,802
Percent Change (as a percent)	3.20%		14.80%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 835	800	$ 2,486	2,236
Percent Change (as a percent)	4.40%		11.20%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 319	302	$ 948	832
Percent Change (as a percent)	5.60%		13.90%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 516	498	$ 1,538	1,404
Percent Change (as a percent)	3.60%		9.50%
MEDICAL DEVICES | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 297	291	$ 934	708
Percent Change (as a percent)	2.10%		31.90%
MEDICAL DEVICES | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 133	130	$ 403	310
Percent Change (as a percent)	2.30%		30.00%
MEDICAL DEVICES | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 164	$ 161	$ 531	$ 398
Percent Change (as a percent)	1.90%		33.40%